Oxidative stress in neurodegenerative diseases

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 83-106

  Simonian, N A ^a   Coyle, J T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; amyotrophic lateral sclerosis; free radicals; Parkinson's disease

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; CATALASE; ENZYME INHIBITOR; FREE RADICAL; NITRIC OXIDE; NORDIHYDROGUAIARETIC ACID; PROTEINASE; SELEGILINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARACHIDONIC ACID METABOLISM; CELL DEATH; DEGENERATIVE DISEASE; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0029888496     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.36.040196.000503     Document Type: Review

References (177)

1. Freeman BA, Crapo JD. 1982. Free radicals and tissue injury. Lab. Invest. 47:412-26
2. McCord JM. 1985. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:159-63
3. Halliwell B, Gutteridge JMC. 1985. Oxygen radicals and the nervous system. Trends Neurosci. 6:22-26
4. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad Sci. USA 87: 1620-24
5. Fridovich I. 1975. Superoxide dismutases. Science 44:147-59
6. Sinet PM, Heikkila RE, Cohen G. 1980. Hydrogen peroxide production by rat brain in vivo. J. Neurochem. 34:1421-28
7. Meister A, Anderson M. 1983. Glutathione. Annu. Rev. Biochem. 52:711-60
8. Lind C, Hochstein P, Ernster L. 1982. DT-diaphorase as a quinone reductase: a cellular control device against semi- quinone and superoxide radical formation. Arch. Biochem. Biophys. 216: 178-85
9. Ernster L. 1987. DT diaphorase: a historical review. Chem. Script. 27:1-13
10. Halliweli B, Borish ET, Pryor WA, Ames BN, Saul RL, et al. 1987. Oxygen radicals and human disease. Ann. Int. Med. 107:526-45
11. Beckman J. 1994. Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury. Ann. NY Acad. Sci. 738:382-87
12. Stadtman E. 1986. Oxidation of proteins by mixed-function oxidation systems. Trends Biol. Sci. 11:11-12
13. Davies KJA. 1987. Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 262:9895-901
14. Stadtman E. 1993. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal catalyzed reactions. Annu. Rev. Biochem. 62:797-821
15. Oliver C, Ahn BA, Moerman EJ, Goldstein S, Stadtman ER. 1987. Age-related changes in oxidized proteins. J. Biol. Chem. 262:5488-91
16. Beckman JS, Chen J, Ischiropoulos H, Crow JP. 1994. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233: 229-40
17. Brawn K, Fridovich I. 1981. DNA strand scission by enzymatically generated oxygen free radicals. Arch. Biochem. Biophys. 206:414-19
18. Kasai H, Nishimura S. 1984. Hydroxyiation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12: 2137-45
19. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, et al. 1986. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogeneas 7:1849-51
20. Ames BN, Shigenaga MK, Hagen TM. 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90:7915-7922
21. Mecocci P, MacGarvey U, Kaufman A, Koontz D, Shoffner J, et al. 1993. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34:609-16
22. Wyllie AH, Kerr JF, Currie AR. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306
23. Schwartzman RA, Cidlowski JA. 1993. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev. 14:133-51
24. Raff MC, Barres BA, Burne JS, Ishizaki Y, Jacobson MD. 1993. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695-700
25. Steller H. 1995. Mechanisms of genes and cellular suicide. Science 267:1445-49
26. Kane DJ, Sarafin TA, Anton R, Hahn H, Gralla EB, et al. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-77
27. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-51
28. Ratan RR, Murphy TH, Baraban JM. 1994. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:376-79
29. Rothstein JD, Bristol LA, Hosler B, Brown RH, Kuncl RW. 1994. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91: 4155-59
30. Troy CM, Shelanski ML. 1994. Down- regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc. Natl. Acad. Sci. USA 91:6384-87
31. Ward J. 1977. Molecular mechanisms of radiation-induced damage to nucleic acids. Adv. Radiat. Biol. 5:181
32. Myers LS. 1980. Free radical damage of nucleic acids and their components. In Free Radicals in Biology, ed. W Pryor, 4:95. New York: Academic
33. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, et al. 1986. Hydrogen-peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 832:4908-12
34. Nicholson DW, Ali A, Thormberry NA, Vaillancourt JP, Ding CK, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
35. Talley AK, Dewhurst S, Parry SW, Dollard SC, Gummuluru S, et al. 1995. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15:2359-66
36. Greenlund L, Deckwerth T, Johnson E. 1995. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14:303-15
37. Jacobson M, Raff M. 1995. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-16
38. Watkins JC, Olverman HJ. 1987. Agonists and antagonists for excitatory amino acids. Trends Neurosci. 10:265-72
39. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:31-108
40. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-34
41. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-95
42. Choi DW. 1995. Calcium: still center- stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:58-60
43. Portera-Cailliau C, Hedreen J, Price D, Koliatsos V. 1995. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15:3775-87
44. Dykens JA, Stern A, Trenkner E. 1987. Mechanisms of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49:1222-28
45. Beal MF. 1992. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6:3338-44
46. Sun AY, Cheng Y, Bu Q, Oldfield F. 1992. The biochemical mechanisms of the excitotoxicity of kainic acid. Mol. Chem. Neuropathol. 17:51-63
47. Lafon-Cazal M, Pletri S, Culcasi M, Bockaert J. 1993. NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-37
48. Miyamoto M, Murphy TH, Schnaar RL, Coyle JT. 1989. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250:1132-40
49. Monyer H, Hartley DM, Choi DW. 1990. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 5:121-26
50. Miyamoto M, Coyle J. 1990. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Exp. Neurol. 108:38-45
51. Puttfarcken PS, Getz RL, Coyle JT. 1993. Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells. Brain Res. 624:223-32
52. Volterra A, Trotti C, Tromba C, Floridi S, Racagni G. 1994. Glutamate uptake inhibition by oxygen free radicals in rat brain cortical astrocytes. J. Neurochem. 14:2924-32
53. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J. Neurosci. 15: 1318-28
54. 2+ loads. J. Neurophysiol. 72:2563-69
55. +: implications for neurodegeneration. J. Neurochem. 63:584-91
56. Beal MF, Hyman BT, Koroshetz W. 1993. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16:125-31
57. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, et al. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13: 4181-92
58. Tipton KE, Singer TP. 1993. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61: 1191-206
59. Schapira AHV, Cooper J, Dexter D, Jenner P, Clark JB, et al. 1989. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54: 823-27
60. 1 reductase (complex I) deficiency in Parkinson's Disease. J. Neurochem. 55:2142-45
61. Bowling AC, Beal MF. 1995. Bioenergetic and oxidative stress in neurodegenerative disease. Life Sci. 56:1151-71
62. Novielli A, Reilly JA, Lysko PG, Henneberry RC. 1988. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:205-12
63. + neurotoxicity by N-methyl-D-aspartate. Nature 349:414-18
64. Sonsalla PK, Zeevalk GD, Manzino L, Giovanni A, Nicklas WJ. 1992. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J. Neurochem. 58:1979-82
65. Boveris A, Chance B. 1973. The mitochondrial generation of hydrogen peroxide. J. Biochem. 134:707-16
66. Hasegawa E, Takeshiga K, Oishi T, Murai Y, Minikami S. 1990. 1-methyl-4-phenylpyridium induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170:1049-55
67. +-induced oxidative injury by deprenyl (selegilene), U-78517F, and DMSO. N. Trends Clin. Neuropharmacol. 8:187-88
68. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, et al. 1992. Transgenic mice with increased Cu/Zn- superoude dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1658-67
69. Schulz JB, Matthews RT, Muqit MMK, Browne SE, Beal MF. 1995. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP- induced neurotoxicily in mice. J. Neurochem. 64:936-39
70. Lowenstein CJ, Snyder SH. 1992. Nitric oxide, a novel biologic messenger. Cell 70:705-7
71. Bredt DS, Snyder SH. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86:9030-33
72. Nowicki JP, Duval D, Poignet A, Scatton B. 1991. Nitric oxide mediates neuronal death after focal ischemia in the rat. Eur. J. Pharmacol. 204:339-40
73. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. 1991. Nitric oxide mediates glutamate neurotoxicily in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88:6368-71
74. Moncada C, Lekieffre D, Avrin B, Meldrum B. 1992. Effect of NO synthetase inhibition on NMDA- and ischemia-induced hippocampal lesions. NeuroReport 3:530-32
75. Dawson VL, Dawson TM, Uhl GR, Snyder SH. 1993. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:2651-61
76. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar purkinje cells. J. Neurosci. 14: 187-97
77. Stamler JS. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-36
78. Hewett SJ, Csernansky CA, Choi DW. 1994. Selective potentiation of NMDA- induced neuronal injury following induction of astrocyte iNOS. Neuron 13: 487-94
79. Lipton S, Choi Y-B, Pan Z-H, Lei SZ, Chen HV, et al. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-32
80. Packer MA, Murphy MP. 1994. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett. 345:237-40
81. Boltanos JP, Heales SJR, Land JM, Clark JB. 1995. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurons and astrocytes in primary culture. J. Neurochem. 64:1965-72
82. Demerle-Pallardy C, Lonchampt MO, Chabrier PE, Braquet P 1991. Absence of implication of the L-arginine/nitric oxide pathway on neuronal injury induced by L-glutamate or hypoxia. Biochem. Biophys. Res. Commun. 181: 456-64
83. Lerner-Natoli M, Rondouin G, Debock F, Bockaert J. 1992. Chronic NO synthase inhibition fails to protect hippocampal neurones against NMDA toxicity. NeuroReport 3:1109-12
84. Pauwels PJ, Leysen JE. 1992. Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus. Neurosci. Lett. 143:27-30
85. Puitfarcken PS, Lyons WE, Coyle JT. 1992. Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells. Neuropharmacology 31:565-75
86. Lafon-Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J. 1993. Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32:1259-66
87. Lei SZ, Pan Z-H, Aggarwal SK, Chen HSV, Hartman J, et al. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor- channel complex. Neuron 8:1087-99
88. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, et al. 1992. Nitric oxide-induced blockade of NMDA receptors. Neuron 8:653-62
89. Bredt D, Snyder S. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11
90. Koh J, Choi DW. 1988. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase. J. Neurosci. 8:2153-63
91. Huang Z, Huang PL, Panahian NP, Dalkara T, Fishman MC, et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-85
92. Bazan NG. 1989. Arachidonic acid in the modulation of excitable membrane function and at the onset of brain damage. Ann. NY Acad. Sci. 559:1-16
93. Williams EJ, Errington ML, Lynch MA, Bliss TVP. 1989. Arachidonic acid induces long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341:739-42
94. Piomelli D, Greengard P. 1990. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol. Sci. 11:367-71
95. Bazan NG. 1970. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta 218:1-10
96. Chan P, Fishman R. 1980. Transient formation of superoxide radicals in polyunsaturated fatty acid-induced brain swelling. J. Neurochem. 35:1004-7
97. Okuda S, Saito H, Katsuki H. 1994. Arachidonic acid: toxic and trophic effects on cultured hippocampal neurons. Neuroscience 63:691-99
98. Dumuis A, Sebben M, Haynes H, Pin JP, Bockaert J. 1988. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336: 68-70
99. Sanfeliu C, Hunt A, Patell AJ. 1990. Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res. 526:241-48
100. Lazarewicz J, Wroblewski J, Costa E. 1990. N-methyl-D-aspartate-sensitive glutamate receptors induce calcium-mediated arachidonic acid release in primary cultures of cerebellar granule cells. J. Neurochem. 55:1875-81
101. Rothman SM, Yamada KA, Lancaster N. 1993. Nordihydroguaiaretic acid attenuates NMDA neurotoxicity-action beyond the receptor. Neuropharmacology 32:1279-88
102. Dugan L, Choi D. 1994. Excitotoxicity, free radicals, and cell membrane changes. Ann. Neurol. 35:S17-S21
103. Yu A, Chan P, Fishman R. 1986. Effect of arachidonic acid on glutamate and gamma-aminobutyric acid uptake in primary cultures of rat cerebral cortical astrocytes and neurons. J. Neurochem. 1986:47
104. Barbour B, Szatkowski M, Ingledew N, Attweli D. 1989. Arachidonic acid induces prolonged inhibition of glutamate uptake into glial cells. Nature 342:818-920
105. Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggion A, et al. 1992. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 59:600-6
106. Miller B, Sarantis M, Traynelis S, Attwell D. 1992. Potentiation of NMDA receptor currents by arachidonic acid. Nature 355:722-25
107. Keyser D, Alger B. 1990. Arachidonic acid modulates hippocampal calcium currents via protein kinase C and oxygen radicals. Neuron 5:545-53
108. Fraser D, Hoehn K, Weiss S, MacVicar B. 1993. Arachidonic acid inhibits sodium currents and synaptic transmission in cultured striatal neurons. Neuron 11: 633-44
109. van Kuijk FJ, Sevanian A, Handelman GJ, Dratz EA. 1987. A new role for phospholipase A2: protection of membranes from lipid peroxidation damage. Trends Biol. Sci. 12:31-34
110. Siman R. 1992. Proteolytic mechansisms for the neurodegeneration of Alzheimer's disease. Ann. NY Acad. Sci. 674:193-202
111. Saido T, Sorimachi H, Suzuki K. 1994. Calpain: new perspectives in molecular diversity and physiologic-pathologic involvement. FASEB J. 8:814-22
112. Yuan J, Shaham S, Ledoux S, Ellis J, Horvitz J. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-52
113. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. 1993. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:1-20
114. Gagliardini V, Fernandez P-A, Lee R, Drexler H, Rotello R, et al. 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-28
115. Salo DC, Pacifici RE, Sin SW, Giulivi C, Davies KJA. 1990. Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J. Biol. Chem. 265:11919-27
116. Grune T, Reinheckel T, Joshi M, Davies K. 1995. Proteolysis in cultured liver epithelial cells during oxidative stress. J. Biol. Chem. 270:2344-51
117. 2+ and proteolysis in lethal oxidative injury in endothelial cells. Am. J. Physiol. 261:C889-96
118. Wang KKW, Yuen P-W. 1994. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. Scl. 15: 412-19
119. Siman R, Noszek J. 1988. Excitatory amino acid actiate calpain 1 and induce structural protein breakdown in vivo. Neuron 1:279-87
120. Squier M, Miller A, Malkinson A, Cohen J. 1994. Calpain activation in apoptosis. J. Cell. Physiol. 159:229-37
121. Caner H, Collins J, Harris S, Kassell N, Lee K. 1993. Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res. 607:354-56
122. Rami A, Krieglstein J. 1993. Protective effect of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609:67-70
123. Saido T, Yokota M, Nagao S, Yamaura I, Tani E, et al. 1993. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268:25239-43
124. Roberts-Lewis J, Savage M, Marcy V, Pinsker L, Siman R. 1994. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons to the ischemic gerbil brain. J. Neurosci. 14: 3934-44
125. Lee K, Frank S, Vanderlish P, Arai A, Lynch G. 1991. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA 88: 7233-37
126. Hong S-C, Goto Y, Lanzino G, Soleau S, Kassell N, et al. 1994. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25: 663-69
127. Bartus RT, Baker KL, Heiser AD, Sawyer S, Dean RL, et al. 1994. Post- ischemic adminstration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J. Cereb. Blood Flow Metab. 14:537-44
128. Di Stasi A, Gallo V, Ceccarini M, Petrucci T. 1991. Neuronal fodrin proteolysis occurs independently of excitatory amino acid-induced neurotoxicity. Neuron 6:445-54
129. Manev H, Favaron M, Siman R, Guidotti A, Costa E. 1991. Glutamate neurotoxicity is independent of calpain I inhibition in primary cultures of cerebellar granule cells. J. Neurochem. 57: 1288-95
130. Saito K-I, Elce JS, Hamos JE, Nixon RA. 1993. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer's disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90:2628-32
131. Wajner M, Harkness R. 1989. Distribution of xanthine dehydrogenase and oxidase activities in human and rabbit tissues. Biochim. Biophys. Acta 991:79-84
132. Starck K, Seubert P, Lynch G, Baudry M. 1989. Proteolytic conversion of xanthine dehydrogenase to xanthine oxidase: evidence against a role for calcium-activated protease (calpain). Biochem. Biophys. Res. Commun. 165: 858-64
133. Moriwaki Y, Yamamoto T, Suda M, Nasako Y, Takahashi S, et al. 1993. Purification and immunohistochemical tissue localization of human xanthine oxidase. Biochim. Biophys. Acta 1164: 327-30
134. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
135. Deng H, Hentati A, Tainer J, Iqbal Z, Cayabyab A, et al. 1993. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261:1047-51
136. Robberecht W, Sapp P, Viaene M, Rosen D, McKenna-Yasek D, et al. 1994. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 62: 384-87
137. Bowling AC, Schulz JB, Brown RH, Beal MF. 1993. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61:2322-25
138. Borchelt D, Lee M, Slunt H, Guarnieri M, Xu Z-S, et al. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possess significant activity. Proc. Natl. Acad. Sci. USA 91:8292-96
139. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-74
140. Wong P, Pardo C, Borchelt D, Lee M, Copeland N, et al. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-16
141. Rabizadeh S, Gralla E, Borchelt DR, Gwinn R, Valentine JS, et al. 1995. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA 92:3024-28
142. Brown R. 1995. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80:687-92
143. Sheinberg H. 1988. The neurotoxicity of copper. In Metal Neurotoxicology, ed. S Bondy, K Prasad, pp. 55-60. Boca Raton, FL: CRC
144. Koh J, Choi D. 1988. Zinc alters excitatory amino acid neurotoxicity on central neurons. J. Neurosci. 8:2164-71
145. Beckman J, Ischiropoulos H, Zhu L, van der Woerd M, Smith C, et al. 1992. Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298:438-45
146. Beckman J, Carson M, Smith C, Koppenol W. 1993. ALS, SOD and peroxynitrite. Nature 364:584
147. Olanow C, Arendash G. 1994. Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 7:548-58
148. Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds G. et al. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:515-20
149. Dexter D, Carayon A, Vidailhet M, Ruberg M, Agid F, et al. 1990. Decreased ferritin levels in brain in Parkinson's disease. J. Neurochem. 52: 16-20
150. Dexter D, Carayon A, Javoy-Agid F, Agid Y, Wells F, et al. 1991. Alterations in the levels of iron, ferriten and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953-75
151. Perry T, Godin D, Hansen S. 1982. Parkinson's Disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:305-10
152. Sofic E, Lange KW, Jellinger K, Riederer P. 1992. Reduced and oxidizied glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:128-30
153. Sian J, Dexter D, Lees A, Daniel S, Agid Y, et al. 1994. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann. Neurol. 36:348-55
154. Dexter D, Sian J, Rose S, Hindmarsh J, Mann V, et al. 1994. Indices of oxidative stress and mitochondrial function in individuals with incidental lewy body disease. Ann. Neurol. 35:38-44
155. Dexter D, Carter C, Wells F, Javoy-Agid F, Agid Y, et al. 1989 Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52 381-89
156. Jenner P, Dexter D, Sian J, Schapira A, Marsden C. 1992. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease. Ann. Neurol. 32:S82-S87
157. Sanchez-Ramos A, Ames BN. 1994. A marker of oxyradical-mediated DNA damage (8-hydroxy-2-deoxyguanosine) is increased in the nigrostriatum of Parkinson's disease brain. Neurodegeneration 3:197-204
158. Group PS. 1993. Effect of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328:176-83
159. + in vivo. Eur. J. Pharmocol. 243:241-47
160. Yankner B, Dawes L, Fisher S, Villa- Komaroff L, Oster-Granite M, et al. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-20
161. Behl C, Davis J, Cole GM, Schubert D. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophy. Res. Commun. 186:944-50
162. Behl C, Davis J, Lesley R, Schubert D. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-27
163. Meda L, Cassatella M, Szendrei G, Otvos L, Baron P, et al. 1995. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374:647-50
164. Hensley K, Carney JM, Mattson M, Aksenova M, Harris M, et al. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270-74
165. Butterfield D, Hensley K, Harris M, Mattson M, Carney J. 1994. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:710-15
166. Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K. 1992. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:18210-17
167. Troncoso J, Costello A, Watson A, Johnson G. 1993. In vitro polymerization of oxidized tau into filaments. Brain Res. 613:313-16
168. Smith M, Taneda S, Richey P, Miyata S, Yan S-D, et al. 1994. Advanced Maillard reaction products are associated with Alzheimer's disease pathology. Proc. Natl. Acad. Sci. USA 91: 5710-14
169. Yan S-D, Chen X, Schmidt A-M, Brett J, Godman G, et al. 1994. Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidative stress. Proc. Natl. Acad. Sci. USA 91:7787-91
170. Yan S-D, Schmidt AM, Anderson GM, Brett J, Mora R, et al. 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:9889-97
171. Smith M, Kutty R, Richey P, Yan S-D, Stern D, et al. 1994. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:42-47
172. Schipper H, Cisse S, Stopa E. 1995. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:758-68
173. Subbarao K, Richardson J, Ang L. 1990. Autopsy samples of Alzheimer's cortex show increased lipid peroxidation in vitro. J. Neurochem. 55:342-45
174. Hajimohammadreza I, Brammer M. 1990. Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Neurosci. Lett. 112:333-37
175. Palmer A, Burns M. 1994. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645:338-42
176. Mecocci P, MacGarvey U, Beal MF. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:747-51
177. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, et al. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88:10540-43